Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

NCT00348504 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00348504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00348504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2003
Completion date
June 30, 2005
Enrollment
1,300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure